Portfolio company
AI-Sight
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
This company develops artificial intelligence software for diabetic retinopathy screening to assist clinicians in diagnostic decision-making for healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Digital Diagnostics
This digital health company provides autonomous AI diagnostic software to healthcare providers for detecting diabetic retinopathy and eye diseases at the point of care.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
Siloam Vision
This company develops AI-enabled retinal imaging systems and diagnostic software for healthcare providers to detect preventable blindness in neonates and adults.
Oivi
The company develops an automated retinal camera and AI platform for primary care providers to screen patients for diabetic eye disease.
SiVIEW
This company develops artificial intelligence software for automated eye examinations and remote refraction for optical retailers and eye care professionals.
Deepeye Medical
This company develops artificial intelligence software that analyses eye scans to provide therapy planning support for ophthalmologists treating retinal diseases.
Aireen
The company develops autonomous software that detects eye and chronic diseases from retinal scans for healthcare providers, optical stores, and screening programmes.
EarlySight
EarlySight develops a cellular-level retinal imaging camera and AI software for eye doctors to detect and monitor ophthalmic diseases at microscopic scales.
